Universal Health Services Inc(UHS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 7.03 | EPS (ttm) | 24.56 | Insider Own | 17.07% | Shs Outstand | 51.7M | Perf Week | 3.12% |
| Market Cap | 10.18B | Forward P/E | 7.19 | EPS next Y | 6.7% | Insider Trans | -0.01% | Shs Float | 48.9M | Perf Month | 2.37% |
| Enterprise Value | 15.44B | PEG | 1.04 | EPS next Q | 5.23 | Inst Own | 91.13% | Short Float | 5.25% | Perf Quarter | 19.27% |
| Income | 1.53B | P/S | 0.56 | EPS this Y | 3.63% | Inst Trans | -0.26% | Short Ratio | 3.03 | Perf Half Y | -7.26% |
| Sales | 18.11B | P/B | 1.35 | EPS next 5Y | 6.93% | ROA | 9.87% | Short Interest | 2.56M | Perf YTD | -20.78% |
| Book/sh | 127.49 | P/C | 73.32 | EPS past 3/5Y | 36.2% 15.93% | ROE | 20.99% | 52W High | -29.88% ($246.32) | Perf Year | -7.17% |
| Cash/sh | 2.36 | P/FCF | 12.04 | Sales past 3/5Y | 9.03% 8.48% | ROIC | 12.79% | 52W Low | 23.3% ($140.08) | Perf 3Y | 31.35% |
| Dividend Est. | $0.82 (0.48%) | EV/EBITDA | 5.72 | EPS Y/Y TTM | 28.53% | Gross Margin | 11.36% | Volatility(W/M) | 3.1% 2.84% | Perf 5Y | 17.15% |
| Dividend TTM | 0.8 | EV/Sales | 0.85 | Sales Y/Y TTM | 10.05% | Oper. Margin | 11.36% | ATR (14) | 5.27 | Perf 10Y | 43.8% |
| Dividend Ex-Date | 2026/9/1 | Quick Ratio | 1.04 | EPS Q/Q | 10.09% | Profit Margin | 8.42% | RSI (14) | 54.35 | Recom | 2.41 |
| Dividend Gr. 3/5Y | - 31.95% | Current Ratio | 1.12 | Sales Q/Q | 8.27% | SMA20 | 0.12% ($172.51) | Beta | 1.03 | Target Price | $192.5 |
| Payout | 3.46% | Debt/Eq | 0.7 | Earnings | 2026/7/27 | SMA50 | 4.76% ($164.87) | Rel Volume | 0.77 | Prev Close | $175.78 |
| Employees | 101500 | LT Debt/Eq | 0.59 | EPS/Sales Surpr. | 0.67% 1.29% | SMA200 | -6.75% ($185.22) | Avg Volume(3M) | 0.85M | Price | $172.72 |
| IPO | 1981/7/9 | Option/Short | Yes/Yes | Trades | 12952 | Volume | 654,803 | Change | -1.74% |
Company
UHS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 A large healthcare company operating hospitals and behavioral health (mental health) facilities across the United States. It runs an extensive network of medical facilities with two main pillars — acute-care general hospitals and mental health/addiction treatment centers — making it a healthcare facility stock whose performance is tied to patient demand and the medical reimbursement environment.
Over the past 1 year, roughly in the middle
30% below its 1-year high.
UHS makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +3.6% this year.
Tap to view numbers
The price looks about right
Trading at 7.0 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +31.4% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.48% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 91.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $10B.
FAQ
What kind of company is UHS?
UHS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of UHS?
The market cap of UHS is approximately $10.2B, ranking 930 within its sector.
Does UHS pay dividends?
UHS has a dividend yield of approximately 0.48%, with an annual dividend of $0.82.
What is the P/E ratio of UHS?
UHS has a P/E ratio of approximately 7.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for UHS?
UHS has recorded a 52-week high of $246.32 and a low of $140.08.